Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Author(s):
Boshuizen, J.; Koopman, L.A.; Krijgsman, O.; Shahrabi, A.; Gresnigt-van den Heuvel, E.; Ligtenberg, M.A.; Vredevoogd, D.W.; Kemper, K.; Kuilman, T.; Song, J.Y.; Pencheva, N.; Mortensen, J.T.; Foppen, M.G.; Rozeman, E.A.; Blank, C.U.; Janmaat, M.L.; Satijn, D.; Breij, E.C.W.; Peeper, D.S.; Parren, P.W.H.I. (0000-0002-4365-3859)
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-02-28
Language
English
Is part of
Nature Medicine (2018), Vol. 24, no. 2, p. 203-+
hdl
1887/96424
doi
10.1038/nm.4472